Research & Development: Page 41

PharmaVoice Team/PharmaVoice

Talent Pool

Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...
By PharmaVoice Team • May 1, 2015
PharmaVoice Team/PharmaVoice

Last Word

Enabling Cancer Immunotherapies Henry Li, Ph.D., VP, Translational Oncology at Crown Bioscience, talks about the challenges of developing new and novel cancer immunotherapeutics. PV: Cancer immunotherapy is a hot area of research now. Why do you think this is? Li: Cancer chemotherapies are toxic ...
By Henry Li • May 1, 2015
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

3D Applications in Medicine

Three-dimensional printing is no longer simple plastic prototypes. Today, 3-D printers can produce fully functional components, including complex mechanisms, batteries, transistors, and LEDs. 3D printing — also known as additive manufacturing — is the process of making three-dimensional solid obj...
By Denise Myshko • May 1, 2015
PharmaVoice Team/PharmaVoice

Early Cancer Detection

For most cancers, diagnosis happens too late, when the cancer has worsened or metastasized. But when cancers are diagnosed early, survival statistics are much higher. For example, the five-year survival rate for patients diagnosed with colorectal cancer is around 90% if diagnosed when the cancer ...
By Denise Myshko • May 1, 2015
PharmaVoice Team/PharmaVoice

2015 HBA Luminaries

The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...
By PharmaVoice Team • April 1, 2015
PharmaVoice Team/PharmaVoice

Innovator's Corner

A New Way to KILL INFECTIONS Mark Offerhaus, Chief Executive of the Dutch firm Micreos, talks about the company’s antibiotic alternative that uses endolysins. Antibiotic resistance is increasingly becoming a serious global threat to public health and is the cause of many common infections, includ...
By Mark Offerhaus • March 1, 2015
PharmaVoice Team/PharmaVoice

Pharma Trax

Putting the “e" in Patient-Reported Outcomes Trending now: Electronic data collection improves data quality, shortens study timelines, and increases the likelihood of regulatory approval. Although transitioning from a pen-and-paper strategy to an electronic patient-reported outcome (ePRO) approac...
By PharmaVoice Team • March 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biotechnology Pool Tony Hunt Repligen Names CEO Repligen, a life-sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs, has appointed Tony Hunt as CEO. Mr. Hunt, currently Repligen’s chief operatin...
By PharmaVoice Team • March 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive comm...
By PharmaVoice Team • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

Last Word

Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 201...
By Peter Saltonstall • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

A New Frontier: Bioelectronics Medicines

The nervous system is essentially the body’s electrical and communication system that wires together all the nerves and organs — starting at the brain and central cord and branching out to every other part of the body. Technological advances have led researchers to consider how the nervous system...
By Denise Myshko • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Outsourcing: Outsourcing in a New Era

Companies continue to examine new ways to optimize operations and capitalize on efficiencies through partnerships. As the industry continues to move to a more patient-centric model, which encompasses all aspects of the continuum from R&D through commercialization, CROs and other service partn...
By Taren Grom • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Executive appointments and promotions in the healthcare industry Pharma Pool Stephen Aselage Retrophin Appoints CEO Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014. Mr. Aselage has more than 30 years of pharmaceutical and biotechnolo...
By PharmaVoice Team • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

C-Suite: Clinical Services

We asked C-suite executives throughout the clinical services ecosystem to provide their insights on what the biggest opportunities for innovation are, what the biggest barriers are, and identify a recent innovation that is improving the process. Dr. Martine Dehlinger-Kremer Global VP, Medical an...
By Taren Grom • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

R&D Crowdsourcing: Crowdsourcing in Pharma

Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...
By Denise Myshko • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Augmented Reality: An Overlap Between the Virtual and the Real World

Augmented reality can take technology to a new level to improve patient outcomes and the healthcare journey. Augmented reality, the technology originally popularized as part of simulators and virtual reality games more than a decade ago, is gaining traction today in the pharma space. AR is relate...
By Taren Grom • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

The Power of the Patient: The Era of Healthcare Consumerism

The step-change towards healthcare consumerism means that healthcare providers are increasingly targeting their products towards patients to help them become more engaged in their own healthcare decision-making along their journey as a patient, focusing on quality and convenience. With this in mi...
By Tim Davis • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Healthcare Storytelling Delivery: In the Digital Age

If you represent a brand, you must tell a story about the features and benefits of your project, so that your target user can make sense of it. Yesterday, a woman named Sharon dragged herself out of bed and shuffled to the shower. She turned on the water and massaged shampoo into her hair. And as...
By Buddy Scalera • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

The Future of Healthcare is Wearable

EHR is connecting our healthcare, the Internet of things is connecting our world, and now wearables are connecting everything else. With health data becoming increasingly more standardized and accessible, there is a future where healthcare is personalized not just to our health, but also to our l...
By Matt Balogh • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

E-Solutions as Part of a Multi-channel Strategy: An Integrated Approach to Reach the Physician

Integrated channel management offers an approach to combine e-solutions and traditional channels into a customized and cost-effective communications and optimization mix. With ever-increasing competition for healthcare providers’ time, attention, and the escalating challenge of access, the tradit...
By Peter Dussias • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Digital Solutions: A New Interface

We need to turn the discussion away from digital solutions, data strategy, or traditional channels and realize that it is all channels of interaction. The relationship between digital and traditional are not independent with one succeeding over another, but interdependent with both supporting the...
By Jeremy Shubert • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Letter from the Editor

2015 and beyond… This is the time of year when we all take a moment to reflect on the events of the past year and what lies ahead. In 2014, the industry went through a burst of deals between several major players — Novartis, Eli Lilly and Company, and GlaxoSmithKline — as they look to refocus on ...
By Taren Grom • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

UpFront

INDUSTRY at Large Bayer Helps Students Pursue Science Bayer Corp. presented a $100,000 two-year grant from the Bayer USA Foundation to Students 2 Science (S2S), an innovative STEM education organization that introduces elementary, middle, and high-school students from northern and central New Je...
By Denise Myshko • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

What's New

Ogilvy CommonHealth Worldwide Acquires Element Marketing Group TrendIng Now: Ogilvy CommonHealth extends focus on reimbursement and market share challenges. Ogilvy CommonHealth Worldwide, the health behavior experts of Ogilvy & Mather, has acquired Element Marketing Group (EMG), a market acce...
By Ann Grey • Nov. 15, 2014